Skip to main content
Top
Published in: Insights into Imaging 1/2018

Open Access 01-02-2018 | Review

Role of magnetic resonance imaging in the management of perianal Crohn’s disease

Authors: Jose C. Gallego, Ana Echarri

Published in: Insights into Imaging | Issue 1/2018

Login to get access

Abstract

Perianal fistulas are a major problem in many patients with Crohn’s disease. These are usually complex fistulas that adversely affect patients’ quality of life, and their clinical management is difficult. Medical treatment sometimes achieves cessation of discharge and closure of the external opening; however, it is difficult to assess the status of the rest of the fistula tract. Magnetic resonance imaging is the method of choice with which to evaluate the condition of perianal fistulas and allows for assessment of the status of inaccessible areas. Magnetic resonance imaging also allows the clinician to evaluate other perianal manifestations of Crohn’s disease that differ from the fistulas. This imaging technique is therefore a fundamental means of patient monitoring. When used in conjunction with assessment of the patient’s morphological findings, it provides information that allows for both quantification of disease severity and evaluation of the response to treatment. New types of magnetic resonance sequences are emerging, such as diffusion, perfusion, and magnetisation transfer. These sequences may serve as biomarkers because they provide information reflecting the changes taking place at the molecular level. This will help to shape a new scenario in the early assessment of the response to treatments such as anti-tumour necrosis factor drugs.

Teaching points

MRI is the method of choice with which to evaluate perianal fistulas.
In perianal Crohn’s disease, MRI is a fundamental means of patient monitoring.
The usefulness of the Van Assche score for patient monitoring remains unclear.
New MRI sequences' diffusion, perfusion, and magnetisation transfer may serve as biomarkers.
Literature
1.
go back to reference Sainio P (1984) Fistula-in-ano in a defined population. Incidence and epidemiological aspects. Ann Chir Gynecol 73:219–224 Sainio P (1984) Fistula-in-ano in a defined population. Incidence and epidemiological aspects. Ann Chir Gynecol 73:219–224
2.
go back to reference Keighley MR, Allan RN (1986) Current status and influence of operation on perianal Crohn’s disease. Int J Color Dis 1:104–107CrossRef Keighley MR, Allan RN (1986) Current status and influence of operation on perianal Crohn’s disease. Int J Color Dis 1:104–107CrossRef
3.
4.
go back to reference Sachar DB, Bodian CA, Goldstein ES, Present DH, Bayless TM, Picco M et al (2005) Is perianal Crohn’s disease associated with intestinal fistulization? Am J Gastroenterol 100:1547–1549CrossRefPubMed Sachar DB, Bodian CA, Goldstein ES, Present DH, Bayless TM, Picco M et al (2005) Is perianal Crohn’s disease associated with intestinal fistulization? Am J Gastroenterol 100:1547–1549CrossRefPubMed
5.
go back to reference Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR et al (2005) Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19(Suppl A):5–36CrossRef Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR et al (2005) Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19(Suppl A):5–36CrossRef
6.
go back to reference Tozer PJ, Whelan K, Phillips RKS, Hart AL (2009) Etiology of perianal Crohn’s disease: role of genetic, microbiological, and immunological factors. Inflamm Bowel Dis 15:1591–1598CrossRefPubMed Tozer PJ, Whelan K, Phillips RKS, Hart AL (2009) Etiology of perianal Crohn’s disease: role of genetic, microbiological, and immunological factors. Inflamm Bowel Dis 15:1591–1598CrossRefPubMed
7.
go back to reference Tozer PJ, Burling D, Gupta A, Phillips RKS, Hart AL (2011) Review article: medical, surgical and radiological management of perianal Crohn’s fistulas. Aliment Pharmacol Ther 33:5–22CrossRefPubMed Tozer PJ, Burling D, Gupta A, Phillips RKS, Hart AL (2011) Review article: medical, surgical and radiological management of perianal Crohn’s fistulas. Aliment Pharmacol Ther 33:5–22CrossRefPubMed
8.
go back to reference Sahni V, Ahmad R (2008) Which method is best for imaging of perianal fistula? Abdom Imaging 33:26–30CrossRefPubMed Sahni V, Ahmad R (2008) Which method is best for imaging of perianal fistula? Abdom Imaging 33:26–30CrossRefPubMed
9.
go back to reference Siddiqui MHR, Ashrafian H, Tozer P, Daulatzai N, Burling D, Hart A et al (2012) A Diagnostic accuracy meta-analysis of endoanal ultrasound and MRI for perianal fistula assessment. Dis Colon Rectum 5:576–585CrossRef Siddiqui MHR, Ashrafian H, Tozer P, Daulatzai N, Burling D, Hart A et al (2012) A Diagnostic accuracy meta-analysis of endoanal ultrasound and MRI for perianal fistula assessment. Dis Colon Rectum 5:576–585CrossRef
10.
go back to reference Bor R, Farkas K, Bàlint A, Szücs M, Ábrahám S, Milassin Á et al (2016) Prospective comparison of magnetic resonance imaging, transrectal and transperineal sonography, and surgical findings in complicated perianal Crohn's disease. J Ultrasound Med 35:2367–2372CrossRefPubMed Bor R, Farkas K, Bàlint A, Szücs M, Ábrahám S, Milassin Á et al (2016) Prospective comparison of magnetic resonance imaging, transrectal and transperineal sonography, and surgical findings in complicated perianal Crohn's disease. J Ultrasound Med 35:2367–2372CrossRefPubMed
11.
go back to reference Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M et al (2010) The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: special situations. J Crohns Colitis 4:3–101CrossRef Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M et al (2010) The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: special situations. J Crohns Colitis 4:3–101CrossRef
12.
go back to reference Panés J, Bouhnik Y, Reinisch W, Stoker J, Taylor SA, Baumgart DC et al (2013) Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis 7:556–585CrossRefPubMed Panés J, Bouhnik Y, Reinisch W, Stoker J, Taylor SA, Baumgart DC et al (2013) Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis 7:556–585CrossRefPubMed
13.
go back to reference Gecse KB, Bemelman W, Kamm MA, Stoker J, Khanna R, Ng SC et al (2014) A global consensus on the diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease. Gut 63:1381–1392CrossRefPubMed Gecse KB, Bemelman W, Kamm MA, Stoker J, Khanna R, Ng SC et al (2014) A global consensus on the diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease. Gut 63:1381–1392CrossRefPubMed
14.
go back to reference de Groof EJ, Cabral VN, Buskens CJ, Morton DG, Hahnloser D, Bemelman WA et al (2016) Systematic review of evidence and consensus on perianal fístula: an analysis of national and international guidelines. Color Dis 18:O119–O134CrossRef de Groof EJ, Cabral VN, Buskens CJ, Morton DG, Hahnloser D, Bemelman WA et al (2016) Systematic review of evidence and consensus on perianal fístula: an analysis of national and international guidelines. Color Dis 18:O119–O134CrossRef
15.
go back to reference Buchanan GN, Halligan S, Taylor S, Williams A, Cohen R, Bartram C (2004) MRI of fistula in ano: inter- and intraobserver agreement and effects of directed education. AJR Am J Roentgenol 183:135–140CrossRefPubMed Buchanan GN, Halligan S, Taylor S, Williams A, Cohen R, Bartram C (2004) MRI of fistula in ano: inter- and intraobserver agreement and effects of directed education. AJR Am J Roentgenol 183:135–140CrossRefPubMed
16.
go back to reference Szurowska E, Wypych J, Izycka-Swieszewska E (2007) Perianal fistulas in Crohn's disease: MRI diagnosis and surgical planning. Abdom Imaging 32:705–718CrossRefPubMed Szurowska E, Wypych J, Izycka-Swieszewska E (2007) Perianal fistulas in Crohn's disease: MRI diagnosis and surgical planning. Abdom Imaging 32:705–718CrossRefPubMed
18.
go back to reference Morris J, Spencer JA, Ambrose NS (2000) MR imaging classification of perianal fistulas and its implications for patient management. Radiographics 20:623–635CrossRefPubMed Morris J, Spencer JA, Ambrose NS (2000) MR imaging classification of perianal fistulas and its implications for patient management. Radiographics 20:623–635CrossRefPubMed
19.
go back to reference Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB (2003) AGA technical review on perianal Crohn’s disease. Gastroenterology 125:1508–1530CrossRefPubMed Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB (2003) AGA technical review on perianal Crohn’s disease. Gastroenterology 125:1508–1530CrossRefPubMed
20.
21.
go back to reference Dwarkasing S, Hussain SM, Hop WCJ, Krestin GP (2004) Anovaginal fistulas: evaluation with endoanal MR imaging. Radiology 231:123–128CrossRefPubMed Dwarkasing S, Hussain SM, Hop WCJ, Krestin GP (2004) Anovaginal fistulas: evaluation with endoanal MR imaging. Radiology 231:123–128CrossRefPubMed
22.
go back to reference Horsthuis K, Stoker J (2004) MRI of perianal Crohn’s disease. AJR Am J Roentgenol 183:1309–1315CrossRefPubMed Horsthuis K, Stoker J (2004) MRI of perianal Crohn’s disease. AJR Am J Roentgenol 183:1309–1315CrossRefPubMed
23.
go back to reference Griffin N, Williams AB, Anderson S, Irwing PM, Sanderson J, Desai N et al (2014) Hidradenitis suppurativa: MRI features in anogenital disease. Dis Colon Rectum 57:762–771CrossRefPubMed Griffin N, Williams AB, Anderson S, Irwing PM, Sanderson J, Desai N et al (2014) Hidradenitis suppurativa: MRI features in anogenital disease. Dis Colon Rectum 57:762–771CrossRefPubMed
25.
go back to reference Bouguen G, Siproudhis L, Bretagne J-F, Bigard M-A, Peyrin-Biroulet L (2010) Nonfistulizing perianal Crohn’s disease: clinical features, epidemiology, and treatment. Inflamm Bowel Dis 16:1431–1442CrossRefPubMed Bouguen G, Siproudhis L, Bretagne J-F, Bigard M-A, Peyrin-Biroulet L (2010) Nonfistulizing perianal Crohn’s disease: clinical features, epidemiology, and treatment. Inflamm Bowel Dis 16:1431–1442CrossRefPubMed
26.
go back to reference Ogawa H, Aneda S, Shibata C, Miura K, Nagao M, Ohnuma S et al (2013) Adenocarcinoma associated with perianal fistulas in Crohn's disease. Anticancer Res 33:685–690PubMed Ogawa H, Aneda S, Shibata C, Miura K, Nagao M, Ohnuma S et al (2013) Adenocarcinoma associated with perianal fistulas in Crohn's disease. Anticancer Res 33:685–690PubMed
27.
go back to reference Irvine EJ (1995) Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. Mc Master IBG Group. J Clin Gastroenterol 20:27–32CrossRefPubMed Irvine EJ (1995) Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. Mc Master IBG Group. J Clin Gastroenterol 20:27–32CrossRefPubMed
28.
go back to reference Present D, Rutgeerts P (1999) Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med 340:1398–1405CrossRefPubMed Present D, Rutgeerts P (1999) Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med 340:1398–1405CrossRefPubMed
29.
go back to reference Bell S, Halligan S, Windsor A (2003) Response of fistulating Crohn’s disease to infliximab treatment assessed by magnetic resonance imaging. Aliment Pharmacol Ther 17:387–393CrossRefPubMed Bell S, Halligan S, Windsor A (2003) Response of fistulating Crohn’s disease to infliximab treatment assessed by magnetic resonance imaging. Aliment Pharmacol Ther 17:387–393CrossRefPubMed
30.
go back to reference Rasul I, Wilson SR, MacRae H, Irwin S, Greenberg GR (2004) Clinical and radiological responses after infliximab treatment for perianal fistulizing Crohn’s disease. Am J Gastroenterol 99:82–88CrossRefPubMed Rasul I, Wilson SR, MacRae H, Irwin S, Greenberg GR (2004) Clinical and radiological responses after infliximab treatment for perianal fistulizing Crohn’s disease. Am J Gastroenterol 99:82–88CrossRefPubMed
31.
go back to reference Van Assche G, Vanbeckevoort D, Bielen D, Coremans G, Aerden I, Noman M et al (2003) Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn’s disease. Am J Gastroenterol 98:332–339CrossRefPubMed Van Assche G, Vanbeckevoort D, Bielen D, Coremans G, Aerden I, Noman M et al (2003) Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn’s disease. Am J Gastroenterol 98:332–339CrossRefPubMed
32.
go back to reference Karmiris K, Bielen D, Vanbeckevoort D, Vermeire S, Coremans G, Rutgeerts P et al (2011) Long-term monitoring of infliximab therapy for perianal fistulizing Crohn’s disease by using magnetic resonance imaging. Clin Gastroenterol Hepatol 9:130–136CrossRefPubMed Karmiris K, Bielen D, Vanbeckevoort D, Vermeire S, Coremans G, Rutgeerts P et al (2011) Long-term monitoring of infliximab therapy for perianal fistulizing Crohn’s disease by using magnetic resonance imaging. Clin Gastroenterol Hepatol 9:130–136CrossRefPubMed
33.
go back to reference Ng SC, Plamondon S, Gupta A, Burling D, Swatton A, Vaizey CJ et al (2009) Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn’s perineal fistulas. Am J Gastroenterol 104:2973–2986CrossRefPubMed Ng SC, Plamondon S, Gupta A, Burling D, Swatton A, Vaizey CJ et al (2009) Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn’s perineal fistulas. Am J Gastroenterol 104:2973–2986CrossRefPubMed
34.
go back to reference Savoye-Collet C, Savoye G, Koning E, Dacher JN, Lerebours E (2011) Fistulizing perianal Crohn’s disease: Contrast-enhanced magnetic resonance imaging assessment at 1 year on maintenance anti-TNF-alpha therapy. Inflamm Bowel Dis 17:1751–1758CrossRefPubMed Savoye-Collet C, Savoye G, Koning E, Dacher JN, Lerebours E (2011) Fistulizing perianal Crohn’s disease: Contrast-enhanced magnetic resonance imaging assessment at 1 year on maintenance anti-TNF-alpha therapy. Inflamm Bowel Dis 17:1751–1758CrossRefPubMed
35.
go back to reference Hortshuis K, Ziech MLW, Bipat S, Spijkerboer AM, de Bruine-Dobben AC, Hommes DW et al (2011) Evaluation of an MRI-based score of disease activity in perianal fistulizing Crohn’s disease. Clin Imaging 35:360–365 Hortshuis K, Ziech MLW, Bipat S, Spijkerboer AM, de Bruine-Dobben AC, Hommes DW et al (2011) Evaluation of an MRI-based score of disease activity in perianal fistulizing Crohn’s disease. Clin Imaging 35:360–365
36.
go back to reference Hori M, Oto A, Orrin S, Suzuki K, Baron RL (2009) Diffusion-weighted MRI: a new tool for the diagnosis of fistula in ano. J Magn Reson Imaging 30:1021–1026CrossRefPubMed Hori M, Oto A, Orrin S, Suzuki K, Baron RL (2009) Diffusion-weighted MRI: a new tool for the diagnosis of fistula in ano. J Magn Reson Imaging 30:1021–1026CrossRefPubMed
37.
go back to reference Dohan A, Eveno C, Oprea R, Pautrat K, Placé V, Pocard M et al (2014) Diffusion-weighted MR imaging for the diagnosis of abscess complicating fistula-in-ano: preliminary experience. Eur Radiol 24:2906–2915CrossRefPubMed Dohan A, Eveno C, Oprea R, Pautrat K, Placé V, Pocard M et al (2014) Diffusion-weighted MR imaging for the diagnosis of abscess complicating fistula-in-ano: preliminary experience. Eur Radiol 24:2906–2915CrossRefPubMed
38.
go back to reference Yoshizako T, Wada A, Takahara T, Kwee TC, Nakamura M, Uchida K et al (2011) Diffusion-weighted MRI for evaluating perianal fistula activity: Feasibility study. Eur J Radiol 81:2049–2053CrossRefPubMed Yoshizako T, Wada A, Takahara T, Kwee TC, Nakamura M, Uchida K et al (2011) Diffusion-weighted MRI for evaluating perianal fistula activity: Feasibility study. Eur J Radiol 81:2049–2053CrossRefPubMed
40.
go back to reference Bakan S, Olgun DC, Kandemirli SG, Tutar O, Samaci C, Dikici S et al (2015) Perianal fistula with and without abscess: assessment of fistula activity using diffusion-weighted magnetic resonance imaging. Iran J Radiol 12:e29084CrossRefPubMedPubMedCentral Bakan S, Olgun DC, Kandemirli SG, Tutar O, Samaci C, Dikici S et al (2015) Perianal fistula with and without abscess: assessment of fistula activity using diffusion-weighted magnetic resonance imaging. Iran J Radiol 12:e29084CrossRefPubMedPubMedCentral
41.
go back to reference Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV et al (1999) Estimating kinetic parameters for dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223–232CrossRefPubMed Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV et al (1999) Estimating kinetic parameters for dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223–232CrossRefPubMed
42.
go back to reference Horsthuis K, Lavini C, Bipat S, Stokkers P, Stoker J (2009) Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity. Radiology 251:380–387CrossRefPubMed Horsthuis K, Lavini C, Bipat S, Stokkers P, Stoker J (2009) Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity. Radiology 251:380–387CrossRefPubMed
43.
go back to reference Ziech MLW, Lavini C, Bipat S, Ponsioen CY, Spijkerboer AM, Stokkers PCF et al (2013) Dynamic contrast-enhanced MRI in determining disease activity in perianal fistulizing crohn disease: a pilot study. AJR Am J Roentgenol 200:W170–W177CrossRefPubMed Ziech MLW, Lavini C, Bipat S, Ponsioen CY, Spijkerboer AM, Stokkers PCF et al (2013) Dynamic contrast-enhanced MRI in determining disease activity in perianal fistulizing crohn disease: a pilot study. AJR Am J Roentgenol 200:W170–W177CrossRefPubMed
44.
go back to reference Pinson C, Dolores M, Cruypeninck Y, Koning E, Dacher JN, Savoye G et al (2017) Magnetization transfer ratio for the assessment of perianal activity in Crohn's disease. Eur Radiol 27:80–87CrossRefPubMed Pinson C, Dolores M, Cruypeninck Y, Koning E, Dacher JN, Savoye G et al (2017) Magnetization transfer ratio for the assessment of perianal activity in Crohn's disease. Eur Radiol 27:80–87CrossRefPubMed
Metadata
Title
Role of magnetic resonance imaging in the management of perianal Crohn’s disease
Authors
Jose C. Gallego
Ana Echarri
Publication date
01-02-2018
Publisher
Springer Berlin Heidelberg
Published in
Insights into Imaging / Issue 1/2018
Electronic ISSN: 1869-4101
DOI
https://doi.org/10.1007/s13244-017-0579-9

Other articles of this Issue 1/2018

Insights into Imaging 1/2018 Go to the issue